Literature DB >> 8681807

Developmentally regulated gene expression of thrombomodulin in postimplantation mouse embryos.

H Weiler-Guettler1, W C Aird, H Rayburn, M Husain, R D Rosenberg.   

Abstract

Embryonic lethality of thrombomodulin-deficient mice has indicated an essential role for this regulator of blood coagulation in murine development. Here, the embryonic expression pattern of thrombomodulin was defined by surveying beta-galactosidase activity in a mouse strain in which the reporter gene was placed under the regulatory control of the endogenous thrombomodulin promoter via homologous recombination in embryonic stem cells. The murine trophoblast was identified as a previously unrecognized anatomical site where TM expression is conserved between humans and mice and may exert a critical function during postimplantation development. Targeted reporter gene expression in mesodermal precursors of the endothelial cell lineage defined thrombomodulin as an early marker of vascular differentiation. Analysis of the thrombomodulin promoter in differentiating ES cells and in transgenic mice provided evidence for a disparate and cell type-specific gene regulatory control mechanism in the parietal yolk sac. The thrombomodulin promoter as defined in this study will allow the targeting of gene expression to the parietal yolk sac of transgenic mice and the initiation of investigations into the role of parietal endoderm in placental function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8681807     DOI: 10.1242/dev.122.7.2271

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  8 in total

1.  A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state.

Authors:  H Weiler-Guettler; P D Christie; D L Beeler; A M Healy; W W Hancock; H Rayburn; J M Edelberg; R D Rosenberg
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

2.  Dose-dependent structural and immunological changes in the placenta and fetal brain in response to systemic inflammation during pregnancy.

Authors:  Anna Chudnovets; Jun Lei; Quan Na; Jie Dong; Harish Narasimhan; Sabra L Klein; Irina Burd
Journal:  Am J Reprod Immunol       Date:  2020-05-22       Impact factor: 3.886

3.  Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells.

Authors:  Rashmi Sood; Shawn Kalloway; Alan E Mast; Cecilia J Hillard; Hartmut Weiler
Journal:  Blood       Date:  2005-12-27       Impact factor: 22.113

4.  Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity.

Authors:  Y Zhang; H Weiler-Guettler; J Chen; O Wilhelm; Y Deng; F Qiu; K Nakagawa; M Klevesath; S Wilhelm; H Böhrer; M Nakagawa; H Graeff; E Martin; D M Stern; R D Rosenberg; R Ziegler; P P Nawroth
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

5.  Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection.

Authors:  Rabea Hinkel; Chiraz El-Aouni; Tonia Olson; Jan Horstkotte; Stefan Mayer; Sebastian Müller; Michael Willhauck; Christine Spitzweg; Franz-Josef Gildehaus; Wolfgang Münzing; Ewald Hannappel; Ildiko Bock-Marquette; J Michael DiMaio; Antonis K Hatzopoulos; Peter Boekstegers; Christian Kupatt
Journal:  Circulation       Date:  2008-04-21       Impact factor: 29.690

6.  Maternal Par4 and platelets contribute to defective placenta formation in mouse embryos lacking thrombomodulin.

Authors:  Rashmi Sood; Lynette Sholl; Berend Isermann; Mark Zogg; Shaun R Coughlin; Hartmut Weiler
Journal:  Blood       Date:  2008-05-19       Impact factor: 22.113

Review 7.  Innate immunity, coagulation and placenta-related adverse pregnancy outcomes.

Authors:  Min Li; S Joseph Huang
Journal:  Thromb Res       Date:  2009-08-14       Impact factor: 3.944

8.  Pregnancy-specific glycoproteins bind integrin αIIbβ3 and inhibit the platelet-fibrinogen interaction.

Authors:  Daniel K Shanley; Patrick A Kiely; Kalyan Golla; Seamus Allen; Kenneth Martin; Ronan T O'Riordan; Melanie Ball; John D Aplin; Bernhard B Singer; Noel Caplice; Niamh Moran; Tom Moore
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.